Diabete Type 2: Clinical Trials

131 trials for Diabete Type 2, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

46 completed, 24 recruiting, 24 unknown, 23 not yet recruiting. 65 Not applicable, 8 Phase 1, 8 Phase 2, 7 Phase 3, 5 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable65Completed 28, Recruiting 11, Not yet recruiting 10, Unknown 10, Active not recruiting 2, Terminated 2, Enrolling by invitation 1, Withdrawn 1
Phase 18Not yet recruiting 4, Completed 2, Recruiting 2
Phase 28Unknown 4, Recruiting 2, Completed 1, Withdrawn 1
Phase 37Recruiting 4, Completed 2, Unknown 1
Phase 45Completed 2, Not yet recruiting 2, Unknown 1
Early Phase 12Not yet recruiting 2

Follow Diabete Type 2: new trials by email Literature Review of Diabete Type 2 trials Research Report on Diabete Type 2

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nutrition Intervention Optimization to Better Utilize Resources and Support Health
Meal kits, No-prep meals, Culinary nutrition classes - Diabete Type 2, Obesity & Overweight
Not applicableNot yet recruitingTufts University4002027-01-012026-10-19
Study Evaluating the Safety and Feasibility of Endoscopic Duodenal Injections of Autologous Mesenchymal Stem Cells
endoscopic duodenal injection of ADMSCs - Diabete Type 2, Insulin Resistant Diabetes (Mellitus)
Not applicableNot yet recruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS152026-10-022026-09-02
Assessing Heart and Brain Metabolism in Type II Diabetes Mellitus Patients Using Carbon-13 MRI
C13 Hyperpolarized pyruvate injection - Diabete Type 2
Early Phase 1Not yet recruitingSunnybrook Health Sciences Centre322026-10-012026-09-15
PATHS-T2D: A Recall-by-Genotype Study of Physiologic and Pharmacologic Responses
Orforglipron - Diabete Type 2, Pharmacogenomic Drug Interaction
Phase 4Not yet recruitingMassachusetts General Hospital1002026-10-012026-08-31
Combined Circulatory and Dietary Interventions for Neuropathy
INF® Therapy, NVIf - Diabete Type 2, Neuropathy, Painful
Not applicableNot yet recruitingLoma Linda University602026-10-012025-10-09
A Clinical Study to Evaluate the Safety and Efficacy of RGB-5088 in Patients With Type 2 Diabetes Mellitus
RGB-5088 - Diabete Mellitus, Diabete Type 2
Phase 1Not yet recruitingHangzhou Reprogenix Bioscience, Inc102026-09-302026-09-08
The Effectiveness of an Occupation-Based Lifestyle Program in Individuals With Type 2 Diabetes
Occupation-Based Lifestyle Program - Diabete Type 2, Diabetes in Adults
Not applicableRecruitingAnkara Medipol University422026-09-012026-09-29
Safety, Tolerability and Efficacy of Semaglutide Depot in Subjects With Type-2 Diabetes Mellitus
SG Depot 2 mg, SG Depot 4 mg, SG Depot 6 mg - Diabete Type 2
Phase 1 / Phase 2RecruitingMapi Pharma Ltd.242026-08-092026-08-20
Traditional Chinese Medicine Fasting Therapy, Ketone Levels, and Metabolic Improvements
Traditional Chinese Medicine Fasting Therapy - Obesity & Overweight, Diabete Type 2
CompletedThe Seventh Affiliated Hospital of Sun Yat-sen University11492026-08-012026-09-25
A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-236A and AD-236B
Treatment A(AD-236A), Treatment B(AD-236B), Treatment C(AD-236A+AD-236B) - Hyperlipidemia, Diabete Type 2
Phase 1Not yet recruitingAddpharma Inc.442026-07-292026-07-28
Impact of Date Consumption on Metabolic Control and Oxidative Stress in Patients With Type 2 Diabetes
3 dates per day consumption - Diabete Type 2
Not applicableNot yet recruitingUniversity Tunis El Manar1302026-07-152026-03-12
Inflammation and Diabetes: Evaluating Antioxidant Levels
No Interventions - Diabete Mellitus, Diabete Type 2
Not yet recruitingIstanbul Bilgi University1802026-07-152026-07-29
A Bridging Study of Efsubaglutide Alfa in Healthy Adults in Brazil
Efsubaglutide Alfa Injection, Placebo - Diabete Type 2
Phase 1Not yet recruitingShanghai Yinnuo Pharmaceutical Technology Co., Ltd.482026-06-012026-04-08
Feasibility of a Person-centered Nursing Intervention on Adherence and Control in Patients With Arterial Hypertension and Diabetes Mellitus.
Education and couseling - Diabete Type 2, Diabetes Education
Not applicableNot yet recruitingUniversidad Autónoma de Bucaramanga1002026-06-012026-06-04
Evaluate the Effect of Remote Exercise Intervention on Blood Glucose Control and Physical Fitness in T2DM Patients
Remote Exercise + Health Education, Health Education - Diabete Type 2, Cardio Respiratory Fitness
Not applicableRecruitingSichuan Academy of Medical Sciences802026-06-012026-06-30
Monitoring of the Sympathetic/Vagal Balance Through Multiparametric Analysis of Heart Rate Variability (HRV)
HOLTER ECG monitoring - Diabete Type 2, Heart Failure
Active not recruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS1502026-05-202026-09-04
Peel Family Diabetes Prevention Program
Family Dyad Health and Wellness Coaching Session, Educational Material - Diabete Type 2
Not applicableRecruitingTrillium Health Partners1402026-05-202026-10-02
A Study to Compare the Pharmacokinetics and Safety of the ATB-U101 and ATB-U1011+ATB-U1012 and ATB-1011+ATB-1012 in Healthy Caucasian Participants
ATB-U101, ATB-1011, ATB-U1011 - Diabete Type 2, Hypertension
Phase 1Not yet recruitingAutotelicbio362026-05-182026-05-15
Effect of Diode Laser, Gudmar and Vinegar in Diabetic Patients During Root Canal Treatment
940 nm diode laser, apple cider vinegar, Gymnema Sylvestre - Diabete Type 2
Not applicableRecruitingSharda University902026-05-012026-05-28
Comorbidity-Oriented Primary Care and Integrated Management for Hypertension and Diabetes Mellitus
Integrated Comorbidity Management Package, Usual Care intervention - Hypertension, Diabete Type 2
Not applicableNot yet recruitingNanchang University9602026-05-012026-04-14

Showing 20 of 131. Sign in to see all of them.

Narrower conditions

Diabetes Mellitus, Type 2 (131)  ·  Diabetes Mellitus (25)  ·  Obesity (20)  ·  Hypertension (12)  ·  Overweight (8)  ·  Cardiovascular Diseases (7)  ·  Diabetic Foot (4)  ·  Diabetes Mellitus, Type 1 (3)  ·  Insulin Resistance (3)  ·  Metabolic Syndrome (3)  ·  Motor Activity (3)  ·  Myocardial Infarction (3)  ·  Non-alcoholic Fatty Liver Disease (3)  ·  Prediabetic State (3)  ·  Anxiety Disorders (2)

Broader conditions

Glucose Metabolism Disorders (131)  ·  Nutritional and Metabolic Diseases (131)  ·  Endocrine System Diseases (130)  ·  Metabolic Diseases (130)  ·  Diabetes Mellitus (106)  ·  Pathological Conditions, Signs and Symptoms (35)  ·  Signs and Symptoms (28)  ·  Body Weight (22)  ·  Cardiovascular Diseases (22)  ·  Nutrition Disorders (22)  ·  Overnutrition (22)  ·  Vascular Diseases (22)  ·  Overweight (14)  ·  Behavior (9)  ·  Pathologic Processes (9)

Interventions

Metformin (6)  ·  dapagliflozin (5)  ·  empagliflozin (4)  ·  Aspirin (2)  ·  Control Groups (2)  ·  Exercise (2)  ·  Sodium-Glucose Transporter 2 Inhibitors (2)  ·  Tablets (2)  ·  Bariatric Surgery (1)  ·  Captopril (1)  ·  Colchicine (1)  ·  Combined Modality Therapy (1)  ·  Connor-Davidson Resilience Scale (1)  ·  Data Collection (1)  ·  Diet, Diabetic (1)

Sponsors

Fondazione Policlinico Universitario Agostino Gemelli IRCCS (3)  ·  Hanlim Pharm. Co., Ltd. (3)  ·  Assiut University (2)  ·  Azienda Ospedaliero, Universitaria Pisana (2)  ·  Cairo University (2)  ·  Minia University (2)  ·  University of Sharjah (2)  ·  Aalborg University (1)  ·  Acibadem University (1)  ·  Addpharma Inc. (1)  ·  Ankara Medipol University (1)  ·  Ashraf Abdelaal (1)  ·  Autotelicbio (1)  ·  Bandırma Onyedi Eylül University (1)  ·  Biolingus (1)

Countries

Italy (12)  ·  United States (12)  ·  China (8)  ·  Turkey (Türkiye) (8)  ·  Canada (7)  ·  Egypt (7)  ·  France (7)  ·  South Korea (7)  ·  India (4)  ·  Brazil (3)  ·  Denmark (3)  ·  Finland (3)  ·  Mexico (3)  ·  Belgium (2)  ·  Greece (2)

Top investigators

Alain Veilleux, PhD (1)  ·  Andrea Natali (1)  ·  Andrea Natali, MD (1)  ·  Anna Torri, MD (1)  ·  Antonio Ambrosi (1)  ·  Antonio Spanevello, Prof (1)  ·  Arne Astrup, MD, PhD (1)  ·  Beryl O'Donnell, MSN, RN, NP-C (1)  ·  Charbel Abi Khalil, MD,PhD (1)  ·  Charles Cunningham, BASc, PhD (1)  ·  Chen Qingqi (1)  ·  Claradina Soto, PhD, MPH (1)

Results publications

PMID 10693087, PMID 10720604, PMID 11239408, PMID 11319655, PMID 11889147, PMID 11926784, PMID 12227125, PMID 12589096, PMID 14975468, PMID 15353531, PMID 15793206, PMID 16291066, PMID 16389125, PMID 16758177, PMID 17277315, PMID 17513708, PMID 18612117, PMID 19158048, PMID 19383872, PMID 19719706, PMID 20032779, PMID 20332511, PMID 20336198, PMID 20655123, PMID 20818193, PMID 20876709, PMID 21228246, PMID 21540423, PMID 21636159, PMID 22030444, PMID 22223765, PMID 22417277, PMID 22883509, PMID 23159553, PMID 23222938, PMID 23435159, PMID 23613782, PMID 23958264, PMID 24657294, PMID 24767584, PMID 24822048, PMID 24843743, PMID 25329391, PMID 25493265, PMID 25538310, PMID 25580754, PMID 25671671, PMID 25705296, PMID 25765355, PMID 25860638

NIH funding

1KL2TR001862-01 (1), 2018 (1), 2019 (1), 2025 (1), R01DK145891 (1), R01DK148455 (1)